---
title: "Xizang Weixinkang Pharmaceutical: Subsidiary's drugs pass the consistency evaluation of generic drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236914612.md"
description: "On the evening of April 22, Xizang Weixinkang Pharmaceutical announced that its wholly-owned subsidiary Inner Mongolia Baiyi Pharmaceutical Co., Ltd. recently received the \"Drug Supplement Application Approval Notice\" issued by the National Medical Products Administration for the potassium magnesium aspartate injection, which has passed the consistency evaluation of quality and efficacy for generic drugs. Potassium magnesium aspartate injection is an electrolyte supplement used for hypokalemia, arrhythmias caused by digitalis poisoning, as well as for the auxiliary treatment of myocarditis sequelae, congestive heart failure, and myocardial infarction"
datetime: "2025-04-22T08:04:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236914612.md)
  - [en](https://longbridge.com/en/news/236914612.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236914612.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical: Subsidiary's drugs pass the consistency evaluation of generic drugs

On the evening of April 22, Xizang Weixinkang Pharmaceutical announced that its wholly-owned subsidiary Inner Mongolia Baiyi Pharmaceutical Co., Ltd. recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration for the potassium magnesium aspartate injection, which has passed the consistency evaluation of quality and efficacy for generic drugs. The potassium magnesium aspartate injection is an electrolyte supplement used for hypokalemia, arrhythmias caused by digitalis poisoning, as well as for the auxiliary treatment of myocarditis sequelae, congestive heart failure, and myocardial infarction

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [Fosun turns page after property writedowns, shifts focus back to growth](https://longbridge.com/en/news/297240299.md)
- [This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/297053341.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [03:39 ETWalovi Accelerates Global Push with WALOVI Singapore HQ Launch and Trio of Southeast Asia Deals](https://longbridge.com/en/news/297003145.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**